HIGHLIGHTS
- who: Zheng Bo et al. from the Department of Neurology, Ya`an People`s Hospital, China have published the paper: Pharmacotherapies for Central Post-Stroke Pain: A Systematic Review and Network Meta-Analysis, in the Journal: Oxidative Medicine and Cellular Longevity 7 of 18/08/2022
- what: The aim of this study is to study the comparative effectiveness among differential pharmacotherapies for CPSP through a network meta-analysis. The analysis showed that, compared with placebo, pamidronate (SMD -2.43, 95% CI -3.54 to -1.31), prednisone (SMD -2.38, 95% CI -3.09 to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.